Table 3 Results of cytology and HR-HPV co-testing performed within 6 months before histological diagnosis of invasive cervical adenocarcinoma
Cytology | HC2 testing (n = 24) | Genotyping (n = 45) | Total (n = 69) | |||
|---|---|---|---|---|---|---|
Negative (%) | Positive (%) | Negative (%) | Positive (%) | Negative (%) | Positive (%) | |
NILM | 3 (12.5) | 6 (25.0) | 6 (13.3) | 1 (2.2) | 9 (13.0) | 7 (10.1) |
Unsatisfactory | 0 (0) | 1 (4.2) | 0 (0) | 1 (2.2) | 0 (0) | 2 (2.9) |
ASC-US | 1 (4.2) | 4 (16.7) | 3 (6.7) | 1 (2.2) | 4 (5.8) | 5 (7.2) |
ASC-H | 0 (0) | 2 (8.3) | 1 (2.2) | 5 (11.1) | 1 (1.4) | 7 (10.1) |
HSIL | 0 (0) | 0 (0) | 0 (0) | 2 (4.4) | 0 (0) | 2 (2.9) |
Cancer cells | 0 (0) | 2 (8.3) | 2 (4.4) | 8 (17.8) | 2 (2.9) | 10 (14.5) |
AGC | 2 (8.3) | 3 (12.5) | 5 (11.1) | 10 (22.2) | 7 (10.1) | 13 (18.8) |
Total | 6 (25.0) | 18 (75.0) | 17 (37.8) | 28 (62.2) | 23 (33.3) | 46 (66.7) |